A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
Suskind
David L
DL
Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital and Regional Medical Center, University of Washington, Seattle, WA 98105, USA. david.suskind@seattlechildrens.org
Finn
Laura
L
Wahbeh
Ghassan
G
Christie
Dennis
D
Horslen
Simon
S
D000015:Abnormalities, Multiple; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002648:Child; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D015209:Cholangitis, Sclerosing / Q000188:drug therapy*; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D002756:Cholagogues and Choleretics; D002792:Cholestyramine Resin; D014580:Ursodeoxycholic Acid